🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Overall Response Rate

Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors NCT05749627NA1 site📍 Nanchang The First Affiliated Hospital of Nanchang University · Tests: Neoantigen peptide vaccine, Neoantigen-based DC immune preparation Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac) NCT06531681n/a1 site📍 Haikou The Second Affiliated Hospital of Hainan Medical University · Tests: MR-Linac Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients NCT04698785Phase 216 sites📍 Besançon📍 Bordeaux📍 Dijon Centre Leon Berard · Tests: Treatment by regorafenib and best supportive care Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer NCT07448142Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Low-dose radiotherapy, Pucotenlimab, CAPEOX/XELOX ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers NCT07238075Phase 19 sites📍 Sydney📍 Sydney📍 Birtinya Adcytherix SAS · Tests: ADCX-020 A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients NCT06277024NA1 site📍 Fuzhou Fujian Medical University · Tests: Combination of Cardonizumab with Lenvatinib and SOX regimen The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) NCT06520345Phase 333 sites📍 Orange📍 Miami📍 Glen Burnie Telix Pharmaceuticals (Innovations) Pty Limited · Tests: 177Lu-TLX591, Enzalutamide, Abiraterone, Docetaxel Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions NCT07090525Phase 21 site📍 Qingdao Qingdao Central Hospital · Tests: Intracavity injection of bevacizumab 7.5mg/kg plus cisplatin 40mg/m2, cisplatin 40mg/m2 intracavity injection Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia NCT06530576Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Thalidomide and methotrexate
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy